🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anastasios Lymperopoulos

Nova Southeastern University

ORCID: 0000-0001-9817-6319
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus”.

Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

Frontiers in Cardiovascular Medicine(2020)10.3389/fcvm.2020.610282
N/A
0.396DataRank · unranked
13 citations

Daniela Rodriguez, Keyvan Yousefi, Krista John‐Williams, Armando J. Mendez, Ronald Goldberg +7 more

βPix sequesters IDOL and prevents LDL receptor degradation through a β 2 AR-regulated signaling pathway in Alport Syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.06.372292
N/A
0DataRank · unranked
0 citations

Keyvan Yousefi, José Manuel Cóndor Capcha, Camila Iansen Irion, Guerline Lambert, Serene A. Shehadeh +15 more

Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function

Cells(2021)10.3390/cells10061552
N/A
0DataRank · unranked
23 citations

Pedro Urquiza, Jordana I. Borges, Anastasios Lymperopoulos, María E. Solesio, Mariona Guitart‐Mampel

RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting

Biochemical Pharmacology(2023)10.1016/j.bcp.2023.115904
N/A
0DataRank · unranked
17 citations

Jordana I. Borges, Renee A. Stoicovy, Anastasios Lymperopoulos

Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?

Expert Review of Clinical Pharmacology(2023)10.1080/17512433.2023.2233891
N/A
0DataRank · unranked
13 citations

Anastasios Lymperopoulos

Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4

International Journal of Molecular Sciences(2023)10.3390/ijms24076136
N/A
0DataRank · unranked
10 citations

Malka S. Suster, Anastasios Lymperopoulos, Jordana I. Borges

Gut microbiota alterations in acute myocardial infarction: (diabetic) context is everything

Annals of Translational Medicine(2023)10.21037/atm-23-1741
N/A
0DataRank · unranked
3 citations

Anastasios Lymperopoulos

The therapeutic potential of targeting cardiac RGS4

Therapeutic Advances in Cardiovascular Disease(2023)10.1177/17539447231199350
N/A
0DataRank · unranked
2 citations

Teresa Baggio Lopez, Anastasios Lymperopoulos, Giselle Del Calvo

Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects

Pharmaceutics(2024)10.3390/pharmaceutics16060693
N/A
0DataRank · unranked
14 citations

Jordana I. Borges, Renee A. Stoicovy, Anastasios Lymperopoulos

RGS Proteins in Sympathetic Nervous System Regulation: Focus on Adrenal RGS4

Frontiers in Bioscience-Landmark(2024)10.31083/j.fbl2910355
N/A
0DataRank · unranked
1 citations

Renee A. Stoicovy, Anastasios Lymperopoulos

Editorial Overview: Adrenergic signaling in cellular physiology and disease

Current Opinion in Physiology(2024)10.1016/j.cophys.2024.100778
N/A
0DataRank · unranked
0 citations

Walter J. Koch, Anastasios Lymperopoulos

Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally Gs Protein-Selective GPCR

International Journal of Molecular Sciences(2025)10.3390/ijms26157239
N/A
0DataRank · unranked
8 citations

Victoria L. Altsman, Renee A. Stoicovy, Anastasios Lymperopoulos